LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 110 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,253,913 | -50.3% | 6,654,966 | +4.3% | 0.00% | – |
| Q2 2023 | $14,608,335 | +6.3% | 6,379,186 | +12.8% | 0.00% | – |
| Q1 2023 | $13,746,332 | +23.0% | 5,656,927 | -3.3% | 0.00% | – |
| Q4 2022 | $11,178,246 | -19.1% | 5,852,485 | +1.6% | 0.00% | – |
| Q3 2022 | $13,823,000 | +64.4% | 5,760,000 | +27.4% | 0.00% | – |
| Q2 2022 | $8,407,000 | -9.5% | 4,519,829 | +1.7% | 0.00% | – |
| Q1 2022 | $9,292,000 | -48.1% | 4,445,752 | -2.2% | 0.00% | – |
| Q4 2021 | $17,920,000 | -19.9% | 4,547,924 | -2.2% | 0.00% | -100.0% |
| Q3 2021 | $22,369,000 | +4.9% | 4,650,670 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $21,329,000 | -6.9% | 4,646,859 | +19.0% | 0.00% | 0.0% |
| Q1 2021 | $22,916,000 | +128.4% | 3,904,147 | +33.1% | 0.00% | – |
| Q4 2020 | $10,033,000 | +78.7% | 2,933,961 | -24.8% | 0.00% | – |
| Q3 2020 | $5,616,000 | -33.2% | 3,901,144 | -7.5% | 0.00% | – |
| Q2 2020 | $8,412,000 | +7.3% | 4,216,972 | +4.9% | 0.00% | – |
| Q1 2020 | $7,842,000 | -53.4% | 4,021,745 | -0.8% | 0.00% | -100.0% |
| Q4 2019 | $16,828,000 | +34.9% | 4,054,634 | -2.2% | 0.00% | 0.0% |
| Q3 2019 | $12,475,000 | -51.1% | 4,143,943 | +2.1% | 0.00% | 0.0% |
| Q2 2019 | $25,536,000 | +11.2% | 4,059,558 | -1.7% | 0.00% | 0.0% |
| Q1 2019 | $22,972,000 | -20.6% | 4,131,522 | -5.2% | 0.00% | 0.0% |
| Q4 2018 | $28,928,000 | -38.5% | 4,356,726 | -1.2% | 0.00% | -50.0% |
| Q3 2018 | $47,029,000 | -11.4% | 4,407,641 | -0.3% | 0.00% | 0.0% |
| Q2 2018 | $53,066,000 | +46.5% | 4,422,293 | +4.6% | 0.00% | 0.0% |
| Q1 2018 | $36,222,000 | -15.8% | 4,226,832 | -3.0% | 0.00% | 0.0% |
| Q4 2017 | $43,038,000 | -27.5% | 4,355,908 | -9.8% | 0.00% | -33.3% |
| Q3 2017 | $59,382,000 | -22.5% | 4,831,653 | +3.7% | 0.00% | -25.0% |
| Q2 2017 | $76,643,000 | +10.0% | 4,659,129 | -4.1% | 0.00% | 0.0% |
| Q1 2017 | $69,670,000 | +30060.2% | 4,858,490 | +28978.8% | 0.00% | – |
| Q4 2016 | $231,000 | -32.5% | 16,708 | -11.7% | 0.00% | – |
| Q3 2016 | $342,000 | +627.7% | 18,932 | +478.8% | 0.00% | – |
| Q2 2016 | $47,000 | -17.5% | 3,271 | -30.9% | 0.00% | – |
| Q1 2016 | $57,000 | +338.5% | 4,733 | +395.6% | 0.00% | – |
| Q4 2015 | $13,000 | +30.0% | 955 | +6.3% | 0.00% | – |
| Q3 2015 | $10,000 | +42.9% | 898 | 0.0% | 0.00% | – |
| Q2 2015 | $7,000 | – | 898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |